BFRI

Biofrontera Inc. [BFRI] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BFRI Stock Summary

Top 10 Correlated ETFs

BFRI

Top 10 Correlated Stocks

BFRI

In the News

BFRI Financial details

Company Rating
-
Market Cap
10.64M
Income
-20.13M
Revenue
34.06M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
83
Optionable
No
Shortable
Yes
Earnings
12 May 2024
P/E
-0.13
Forward P/E
-
PEG
-0
P/S
0.11
P/B
3.23
P/C
-
P/FCF
-0.15
Quick Ratio
0.46
Current Ratio
1.02
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-15.82
EPS next Y
-
EPS next Q
-
EPS this Y
2034.43%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-6.37%
Revenue last 5Y
5.41%
Revenue Q/Q
19.34%
EPS Q/Q
-135.56%
-
-
-
-
SMA20
-16.3%
SMA50
-27.36%
SMA100
-9.41%
Inst Own
-
Inst Trans
-
ROA
-78%
ROE
-217%
ROC
-4.89%
Gross Margin
49%
Oper. Margin
-72%
Profit Margin
-79%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.61-13.42
52W High
-
52W Low
-
RSI
48.38
Rel Volume
0.06
Avg Volume
802.19K
Volume
49.25K
Perf Week
4.87%
Perf Month
-13.87%
Perf Quarter
11.85%
Perf Half Y
1.16%
-
-
-
-
Beta
0.838
-
-
Volatility
0.05%, 0.08%
Prev Close
3.83%
Price
0.84
Change
18.31%

Something similar

Top by Market Cap
CMC.DE
VTSAX
ABEC.DE
BRK-A
FB2A.DE
Top Correlated ETFs
HDRO
HDRO.L
367770.KS
HYGN.L
HDGB.L
Top Correlated Stocks
VXRT
FGP.L
BLDP
AAD.DE
GLUE
Similar Market Cap
SALM
FCHY.TO
AUSI
PRM.L
HELX

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 802.19K
  • Market Capitalization 10.64M
  • Employee 83
  • CEO Dr. Hermann Luebbert Ph.D.
  • Headquarters Woburn,MA,US
  • IPO Date 2021-10-29
  • Website https://www.biofrontera.us.com

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.